Dr. Sunny Joseph Haft, MD

Dr. Haft practices at Univ of Maryland Otorhinolaryngology Head & Neck Surgery PA in Baltimore, Maryland.

Dr. Haft's NPI, 1962817098, was assigned on June 27, 2014. Dr. Haft graduated from University of Ottawa, Faculty of Medicine in 2014. Dr. Haft holds Maryland license D0089572.

Dr. Haft's primary practice is Univ of Maryland Otorhinolaryngology Head & Neck Surgery PA, at 16 S Eutaw St, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-6897.

Dr. Haft's primary practice is Univ of Maryland Otorhinolaryngology Head & Neck Surgery PA in Baltimore, Maryland. Dr. Haft is also affiliated with Greenwich Hospital. The medical group on file is Univ Of Maryland Otorhinolaryngology Head & Neck Surgery Pa. Dmand AI also links Dr. Haft to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haft practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Haft's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Haft is licensed in Maryland.

CMS data shows 601 Medicare services from Dr. Haft across 9 procedure codes in 2024, for 387 Medicare patients. Medicare paid $33,839 for them.

CMS counts 387 Medicare patients who saw Dr. Haft in 2024. The largest group is 75 to 84, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Haft's median patient age at 65, with 53% women.

In 2024, Dr. Haft wrote 152 Medicare Part D claims for 72 patients. 92% of them were for generic drugs. CMS names the drug for 89 of them, across 4 drugs with 11 or more claims each, at $2,501 in total drug cost. In 2023, CMS named 53 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Haft for performance year 2024, reported as part of a group. Dr. Haft accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Haft, published from 2014 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Squamous Cell Carcinoma of Head and Neck, Gene Expression Regulation, Neoplastic and Cell Line, Tumor. Dr. Haft has published most often in Clin Cancer Res. Dr. Haft's most frequent co-authors are Joseph A. Califano, MD, Theresa Wen Wen Guo, MD and Natasha Mirza, MD.

CMS Open Payments shows 81 general payments to Dr. Haft from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 61% of the total. Inspire Medical Systems, Inc. paid the most, $1,855.

Dr. Haft graduated from University of Ottawa, Faculty of Medicine in 2014.